US45258D1054
US45258D1054
Immunocore Holdings plc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.51B EUR | 1.63B EUR | 1.53B EUR | 1.76B EUR |
Enterprise Value | 1.05B EUR | 1.58B EUR | 1.52B EUR | 1.73B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -38.96x | -- | -- | -- |
Price to Sales | 3.51x | 3.79x | 3.71x | 5.75x |
Price to Book | 3.6x | 3.89x | 3.89x | 4.62x |
EV/Revenue | 2.44x | 3.68x | 3.67x | 5.65x |
EV/EBITDA | 1,392.65x | 144.56x | 1,300.94x | -- |
Price to FCF (P/FCF) | 42.52x | -- | -- | -- |
EV/FCF | 29.58x | -- | -- | -- |
FCF Yield | 2.35% | -2.52% | -2.01% | -0.86% |